Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis

被引:57
作者
Schwarz, EM
Looney, RJ
O'Keefe, RJ
机构
[1] Univ Rochester, Med Ctr, Dept Med, Immunol Rheumatol, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA
关键词
aseptic loosening; osteolysis; pannus; prosthesis; tumor necrosis factor-alpha;
D O I
10.1186/ar81
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aseptic loosening of total joint arthroplastics due to periprosthetic osteolysis is a frequent cause of implant failure. The absence of clinical interventions to arrest or prevent this complication limits the use of total joint replacement especially in younger patients. Here we review recent studies implicating tumor necrosis factor (TNF)-alpha in periprosthetic osteolysis and the rationale for clinical studies of anti-TNF therapy and other interventions for periprosthetic loosening.
引用
收藏
页码:165 / 168
页数:4
相关论文
共 43 条
[1]  
ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles [J].
Blaine, TA ;
Rosier, RN ;
Puzas, JE ;
Looney, RJ ;
Reynolds, PR ;
Reynolds, SD ;
OKeefe, RJ .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1996, 78A (08) :1181-1192
[4]  
Boyce BF, 1999, LAB INVEST, V79, P83
[5]   RESULTS OF REVISION FOR MECHANICAL FAILURE AFTER CEMENTED TOTAL HIP-REPLACEMENT, 1979 TO 1982 - A 2 TO 5-YEAR FOLLOW-UP [J].
CALLAGHAN, JJ ;
SALVATI, EA ;
PELLICCI, PM ;
WILSON, PD ;
RANAWAT, CS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1985, 67A (07) :1074-1085
[6]   Charnley total hip arthroplasty in patients less than fifty years old - A twenty to twenty-five-year follow-up note [J].
Callaghan, JJ ;
Forest, EE ;
Olejniczak, JP ;
Goetz, DD ;
Johnston, RC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (05) :704-714
[7]  
Childs LM, 1999, ARTHRITIS RHEUM, V42, pS154
[8]  
Clohisy JC, 1999, J BONE MINER RES, V14, pS489
[9]   RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[10]   Increased bone mass with pamidronate treatment in rheumatoid arthritis - Results of a three-year randomized, double-blind trial [J].
Eggelmeijer, F ;
Papapoulos, SE ;
vanPaassen, HC ;
Dijkmans, BAC ;
Valkema, R ;
Westedt, ML ;
Landman, JO ;
Pauwels, EKJ ;
Breedveld, FC .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :396-402